To explore how extemporaneous formulations can address the challenges in pharmaceutical manufacturing for personalized medicines.
Analyzed current pharmaceutical manufacturing processes
Evaluated the benefits of personalized versus standardized medicines
Identified gaps in existing therapeutic strategies
Personalized medicines demonstrate higher patient satisfaction and effectiveness
Standardized processes are insufficient for diverse patient needs
Extemporaneous formulations can enhance treatment options and support individualized care
Abstract
The progressive shift of healthcare systems toward personalised and patient-centred therapeutic strategies has exposed the structural limitations of standardised pharmaceutical manufacturing ...